Innovative hematological strategies to combat maternal and child mortality in africa focus on anemia and sickle cell disease

Maternal and child mortality remain pressing public health challenges in Africa, driven by preventable hematological disorders such as anemia, hemorrhage, malaria-induced hemolysis, and hematologic complications of infections. These conditions are further compounded by limited diagnostic infrastructure and delayed access to advanced interventions. This narrative review explores emerging and innovative hematological strategies aimed at reducing maternal and child deaths across the continent. It highlights the role of novel diagnostic tools such as point-of-care hematology analyzers, genetic screening for inherited blood disorders, and rapid hemoglobin quantification in improving early detection and treatment. Advancements in iron supplementation, transfusion safety, and regenerative hematology, including the use of stem cell-based therapies, are discussed as transformative solutions. Moreover, the integration of digital health platforms and community-based blood surveillance systems offers new opportunities to strengthen maternal and neonatal care. By synthesizing current evidence, this review underscores the potential of hematology-centered innovations to close equity gaps, enhance survival outcomes, and accelerate progress toward the Sustainable Development Goals (SDG 3.1 and 3.2) in Africa.